<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        121-124-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LIVADOR 250 MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVOFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        7
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA12 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>What Livador</strong><strong><sup>&reg;</sup></strong><strong> Tablets are</strong></p><p>The name of your medicine is <strong>Livador<sup>&reg;</sup> </strong>Tablets. <strong>Livador<sup>&reg;</sup> </strong>Tablets contain a medicine called levofloxacin. This belongs to a group of medicines called antibiotics. Levofloxacin is a &lsquo;quinolone&rsquo; antibiotic. It works by killing the bacteria that cause infections in your body.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>What Livador<sup>&reg;</sup> Tablets are used for </strong></p><p><strong>Livador<sup>&reg;</sup></strong> Tablets can be used to treat infections of the:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sinuses</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lungs, in people with long-term breathing problems or pneumonia</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urinary tract, including your kidneys or bladder</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prostate gland, where you have a long-lasting infection</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and underneath the skin, including muscles. This is sometimes called &lsquo;soft tissue&rsquo;</p><p>In some special situations, levofloxacin may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not take Livador<sup>&reg;</sup> Tablets if:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are allergic to levofloxacin or any other quinolone antibiotics such as moxifloxacin, ciprofloxacin or ofloxacin or any of the other ingredients of <strong>Livador<sup>&reg;</sup></strong> Tablets. Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your eyesight becomes impaired or if your eyes seem to be otherwise affected, consult an eye specialist immediately.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had epilepsy.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had a problem with your tendons such as tendonitis that was related to treatment with a &lsquo;quinolone antibiotic&#39;. A tendon is the cord that joins your muscle to your skeleton.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are a child or a growing teenager.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are pregnant, might become pregnant or think you may be pregnant.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are breast-feeding.</p><p>Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking <strong>Livador<sup>&reg;</sup></strong> Tablets.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Take special care with Livador<sup>&reg;</sup> Tablets. </strong></p><p>Talk to your doctor or pharmacist before taking your medicine if:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; You are 60 years of age or older.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You are using corticosteroids, sometimes called steroids.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have ever had a fit (seizure).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have had damage to your brain due to a stroke or other brain injury.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have kidney problems.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have something known as &lsquo;glucose &ndash; 6 &ndash;phosphate dehydrogenase deficiency&rsquo;. You are more likely to have serious problems with your blood when taking this medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have ever had mental health problems.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; You have ever had heart problems. Caution should be taken when using this kind of medicine, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You are diabetic.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;You have ever had liver problems.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; You have myasthenia gravis (long-term neuromuscular disease)</p><p><strong>Other warnings</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin may rarely cause pain and inflammation in tendons. Particularly if you are elderly or are taking steroid medicines (such as cortisone or hydrocortisone). If you have any problems with your tendons whilst or shortly after taking levofloxacin, seek medical advice at once and rest the affected limb (leg or arm). Do not take the next dose of levofloxacin unless your doctor tells you to. In such as cases, you experience swelling or pain in the area of affected tendon. It may be necessary to stop treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you start having severe, persistent and/or bloody diarrhoea during or after treatment with levofloxacin, tell your doctor immediately. This could mean you have serious inflammation of your bowel (pseudomembranous colitis), which can sometimes occur after antibiotic treatment. You may need to stop taking levofloxacin and for your doctor to give you another medicine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Whilst taking Levofloxacin you are advised to stay out of strong sunlight and not to use a sun lamp. This is because some patients may become more sensitive to light whilst taking levofloxacin and get a sun-burn like reaction.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin should be discontinued if the patient experiences symptoms burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin is not an optimal therapy for most severe cases of Pneumococcal pneumonia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections got from a hospital during treatment due to P.aeruginosa may require combination therapy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin is not effective against infections caused by MRSA. In infections suspicious for MRSA levofloxacin should be combined with an agent approved to treat MRSA infections.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking <strong>Livador<sup>&reg;</sup></strong> Tablets.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp; <strong>Taking other medicines, herbal or dietary supplements:</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This is because <strong>Livador<sup>&reg;</sup></strong> Tablets can affect the way some other medicines work. Also, some medicines can affect the way <strong>Livador<sup>&reg;</sup></strong> Tablets work.</p><p>In particular, tell your doctor if you are taking any of the following medicines. This is because it can increase the chance of you getting side effects, when taken with <strong>Livador</strong><sup>&reg;</sup> Tablets:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids, sometimes called steroids &ndash; used for inflammation. You may be more likely to have inflammation and/or breakage of your tendons.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warfarin - used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Theophylline - used for breathing problems. You are more likely to have a fit (seizure) if taken with levofloxacin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-steroidal anti-inflammatory drugs (NSAIDs) - used for pain and inflammation such as aspirin, ibuprofen, fenbufen, ketoprofen and indomethacin. You are more likely to have a fit (seizure) if taken with levofloxacin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciclosporin - used after organ transplants. You may be more likely to get the side effects of ciclosporin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines known to affect the way your heart beats. This includes medicines used for abnormal heart rhythm (antiarrhythmic such as quinidine and amiodarone), for depression (tricyclic antidepressants such as amitriptyline and imipramine) and for bacterial infections (&lsquo;macrolide&rsquo; antibiotics such as erythromycin, azithromycin and clarithromycin).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid - used for gout, cimetidine - used for ulcers and heartburn. Special care should be taken when taking either of these medicines with levofloxacin. If you have kidney problems, your doctor may want to give you a lower dose.</p><p>Do not take <strong>Livador</strong><sup>&reg;</sup> Tablets at the same time as the following medicines. This is because it can affect the way levofloxacin works:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Iron tablets (for anemia), zinc supplements, magnesium or aluminum-containing antacids (for acid or heartburn), didanosine, or sucralfate (for stomach ulcers).</p><p><u>Urine tests for opiates</u></p><p>Urine tests may show &lsquo;false-positive&rsquo; results for strong painkillers called &lsquo;opiates&rsquo; in people taking levofloxacin. If your doctor is due to take a urine test, tell him you are taking <strong>Livador<sup>&reg;</sup></strong> Tablets.</p><p><u>Tuberculosis tests</u></p><p>This medicine may cause &ldquo;false-negative&rdquo; results for some laboratory tests that search for the bacteria that cause tuberculosis.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Taking </strong><strong>Livador</strong><sup>&reg;</sup><strong> Tablets with food and drink</strong></p><p>Take without regard to meals. Take with water, drink with plenty of water. Taking this product with orange juice can result in reduced quinolone plasma levels.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp; <strong>Pregnancy and breast-feeding:</strong></p><p>Do not take <strong>Livador</strong><sup>&reg;</sup> Tablets if:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are pregnant, might become pregnant or think you may be pregnant</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are breast-feeding or planning to breast-feed</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp; <strong>Driving and using machines:</strong></p><p>You may get side effects after taking this medicine, including feeling dizzy, sleepy, a spinning feeling (vertigo) or changes to your eyesight. Some of these side effects can affect you being able to concentrate and your reaction speed. If this happens, do not drive or carry out any work that requires a high level of attention.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Livador<sup>&reg;</sup></strong> tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets whole with a drink of water</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The tablets may be taken during meals or at any time between meals</p><p>Protect your skin from sunlight</p><p>Keep out of direct sunlight while taking this medicine and for 2 days after you stop taking it. This is because your skin will become much more sensitive to the sun and may burn, tingle or severely blister if you do not take the following precautions:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure you use high factor sun cream</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always wear a hat and clothes which cover your arms and legs</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Avoid sun beds</p><p><strong>&nbsp;</strong><strong>If you are already taking iron tablets, antacids or sulcralfate</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take these medicines at the same time with <strong>Livador</strong><sup>&reg;</sup>. Take your dose at least 2 hours before or after <strong>Livador</strong><sup>&reg;</sup> Tablets.</p><p><strong>How much to take</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will decide on how many <strong>Livador</strong><sup>&reg;</sup> Tablets you should take.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dose will depend on the type of infection you have and where the infection is in your body.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The length of your treatment will depend on how serious your infection is.&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel the effect of your medicine is too weak or strong, do not change the dose yourself, but ask your doctor.</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Adults and the elderly:</u></strong></p><p><strong>Sinuses</strong> <strong>infection</strong>:</p><p>Two tablets of <strong>Livador</strong><sup>&reg; </sup>250mg, once each day, or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500 mg or 750mg, once each day.</p><p><strong>Lungs infection, in people with long-term breathing problems</strong>:</p><p>Two tablets of <strong>Livador</strong><sup>&reg; </sup>250mg, once each day or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500mg, once each day.</p><p><strong>Pneumonia: </strong></p><p>Two tablets of <strong>Livador</strong><sup>&reg;</sup> 250 mg, once or twice<strong> </strong>each day,<strong> </strong>or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500 mg, once or<strong> </strong>twice each day, or one tablet of <strong>Livador</strong><sup>&reg;</sup> 750 mg, once each day.</p><p><strong>Infection of urinary tract, including your kidneys or bladder: </strong></p><p>One or two tablets of <strong>Livador</strong><sup>&reg;</sup> 250 mg, each day, or, &frac12; or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500 mg, each day<strong>, </strong>or, one tablet of <strong>Livador</strong><sup>&reg;</sup> 750 mg, once each day.</p><p><strong>Prostate gland infection: </strong></p><p>Two tablets of <strong>Livador</strong><sup>&reg;</sup> 250 mg, once each day,<strong> </strong>or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500 mg, once each day.</p><p><strong>Infection of skin and underneath the skin, including muscles: </strong></p><p>Two tablets of <strong>Livador</strong><sup>&reg;</sup> 250 mg, once<strong> </strong>or twice each day, or one tablet of <strong>Livador</strong><sup>&reg;</sup></p><p>500 mg, once or twice each day or one tablet of <strong>Livador</strong><sup>&reg;</sup> 750 mg, once each day.</p><p><strong>Inhalational Anthrax (Post-Exposure)</strong></p><p>Two tablets of <strong>Livador</strong><sup>&reg;</sup> 250 mg once<strong> </strong>daily, or one tablet of <strong>Livador</strong><sup>&reg;</sup> 500 mg once daily.</p><p><strong><u>Adults and the elderly with kidney problems: </u></strong></p><p>Your doctor may need to give you a lower dose.</p><p><strong><u>Children and teenagers:</u></strong></p><p>This medicine must not be given to children or teenagers.</p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you take more Livador<sup>&reg;</sup> Tablets than you should</strong></p><p>If you accidentally take more tablets than you should, tell a doctor or get other medical advice straight away. Take the medicine pack with you. This is so the doctor knows what you have taken. The following effects may happen: convulsive fits (seizures), feeling confused, dizzy, and less conscious, having tremor and heart problems leading to uneven heart beats as well as feeling sick (nausea) or having stomach burning.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you forget to take Livador<sup>&reg;</sup> Tablets</strong></p><p>If you forgot to take a dose, take it as soon as you remember unless it is nearly time for your next dose. Do not double-up the next dose to make up for the missed dose.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you stop taking Livador<sup>&reg;</sup> Tablets</strong></p><p>Do not stop taking <strong>Livador</strong><sup>&reg;</sup> Tablets just because you feel better. It is important that you complete the course of tablets that your doctor has prescribed for you. If you stop taking the tablets too soon, the infection may return, your condition may get worse or the bacteria may become resistant to the medicine.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Livador</strong><sup>&reg;</sup> can cause side effects, although not everybody gets them.</p><p><strong>Stop taking Livador<sup>&reg;</sup> Tablets and see a doctor or go to a hospital straight away if you notice the following side effects:</strong></p><p><strong>Very rare (affects less than 1 person in 10,000)</strong></p><p>&bull; You have an allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat, or tongue.</p><p><strong>Stop taking Livador</strong><sup>&reg;</sup> <strong>Tablets</strong><strong> and see a doctor straight away if you notice any of the following serious side effects &ndash; you may need urgent medical treatment:</strong></p><p><strong>Rare (affects less than 1 person in 1000)</strong></p><p>&bull; Watery diarrhea which may have blood in it, possibly with stomach cramps and a high temperature. These could be signs of a severe bowel problem.</p><p>&bull; Pain and inflammation in your tendons or ligaments, which could lead to rupture. The Achilles tendon is affected most often and in some cases.</p><p>&bull; Fits (convulsions).</p><p><strong>Very rare (affects less than 1 person in 10,000)</strong></p><p>&bull; Burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;.</p><p><strong>Not known </strong><strong>(frequency cannot be estimated from the available data)</strong></p><p>&bull; Severe skin rashes which may include blistering or peeling of the skin around your lips, eyes, mouth, nose and genitals.</p><p>&bull; Loss of appetite, skin and eyes becoming yellow in colour, dark-colored urine, itching, or tender stomach (abdomen). These may be signs of liver problems which may include a fatal failure of the liver.</p><p>If your eyesight becomes impaired or if you have any other eye disturbances whilst taking levofloxacin, consult an eye specialist immediately.</p><p><strong>Tell your doctor if any of the following side effects gets serious or lasts longer than a few days:</strong></p><p><strong>Common (affects less than 1 person in 10)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleeping problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, feeling dizzy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea, vomiting) and diarrhea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in the level of some liver enzymes in your blood</p><p><strong>Uncommon (affects less than 1 person in 100)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of other bacteria or fungi, infection by fungi named candida, which may need to be treated</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of white blood cells shown up in the results of some blood tests (leukopenia, eosinophilia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling stressed (anxiety), feeling confused, feeling nervous, feeling sleepy, trembling, a spinning feeling (vertigo)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath (dyspnoea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things taste, loss of appetite, stomach upset or indigestion (dyspepsia), pain in your stomach area, feeling bloated (flatulence) or constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching and skin rash, severe itching or hives (urticaria), sweating too much (hyperhidrosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint pain or muscle pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood tests may show unusual results due to liver (bilirubin increased) or kidney (creatinine increased) problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General weakness</p><p><strong>Rare (may affect up to 1 in 1,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bruising and bleeding easily due to a lowering in the number of blood platelets (thrombocytopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low number of white blood cells (neutropenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exaggerated immune response (hypersensitivity)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering of your blood sugar levels (hypoglycaemia). This is important for people that have diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seeing or hearing things that are not there (hallucinations, paranoia), change in your opinion and thoughts (psychotic reactions) with a risk of having suicidal thoughts or actions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling depressed, mental problems, feeling restless (agitation), abnormal dreams or nightmares</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tingly feeling in your hands and feet (paraesthesia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your hearing (tinnitus) or eyesight (blurred vision)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusual fast beating of your heart (tachycardia) or low blood pressure (hypotension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness. This is important in people with myasthenia gravis (a rare disease of the nervous system).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way your kidney works and occasional kidney failure which may be due to an allergic kidney reaction called interstitial nephritis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering in red blood cells (anemia): this can make the skin pale or yellow due to damage of the red blood cells; lowering in the number of all types of blood cells (pancytopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, sore throat and a general feeling of being unwell that does not go away. This may be due to a lowering in the number of white blood cells (agranulocytosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of circulation (anaphylactic like shock)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of your blood sugar levels (hyperglycaemia) or lowering of your blood sugar levels leading to coma (hypoglycaemic coma). This is important for people that have diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things smell, loss of smell or taste (parosmia, anosmia, ageusia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems moving and walking (dyskinesia, extrapyramidal disorders)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of consciousness or posture (syncope)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of vision, inflammation of the eye</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment or loss of hearing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal fast heart rhythm, life-threatening irregular heart rhythm including cardiac arrest, alteration of the heart rhythm (called &lsquo;prolongation of QT interval&rsquo;, seen on ECG, electrical activity of the heart)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty breathing or wheezing (bronchospasm)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic lung reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancreatitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the liver (hepatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sensitivity of your skin to sun and ultraviolet light (photosensitivity)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the vessels that carry blood around your body due to an allergic reaction (vasculitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the tissue inside the mouth (stomatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle rupture and muscle destruction (rhabdomyolysis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint redness and swelling (arthritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain, including pain in the back, chest and extremities</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attacks of porphyria in people who already have porphyria (a very rare metabolic disease)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Persistent headache with or without blurred vision (benign intracranial hypertension)</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&minus; Keep out of the reach and sight of children.</p><p>&minus; Store below 30&deg;C.</p><p>&minus; Do not take <strong>Livador</strong><sup>&reg;</sup> Tablets after the expiry date which is printed on the outside of the pack. The expiry date refers to the last day of that month.</p><p>&minus; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>What Livador<sup>&reg;</sup> Tablets contain</strong></p><p><strong>Livador</strong><sup>&reg;</sup> is available in strengths containing 250, 500 or 750 mg of the active ingredient, Levofloxacin (as levofloxacin hemihydrate).</p><p>The other ingredients are: Crospovidone, microcrystalline cellulose, sodium stearyl fumarate, hypromellose, talc, yellow iron oxide (E172), red iron oxide (E172), Opadry-Y-1-7000 (hypromellose, titanium dioxide, macrogol).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                •	What Livador® Tablets look like and contents of the pack
	What Livador® Tablets look like
Livador® 250 Film Coated Tablets are light pink, oblong shaped film coated tablets with a mid-groove on both sides, coded (MAT250) on one side, plain on the other side.
Livador® 500 Film Coated Tablets are light pink, oblong shaped film coated tablets with a mid-groove on both sides, coded (MAT500) on one side, plain on the other side.
Livador® 750 Film Coated Tablets are light pink, oval normal biconvex film coated tablets coded (MAT750) on one side, plain on the other side.

	Contents of the pack of Livador® Tablets 
Livador® is packed in aluminium blisters.
Livador® 250 Film Coated Tablets: Packs of 7 tablets (one blister) and 350 tablets (50 blisters). Each tablet contains 250 mg Levofloxacin (as levofloxacin hemihydrate).
Livador® 500 Film Coated Tablets: Packs of 7 tablets (one blister) and 350 tablets (50 bilsters). Each tablet contains 500 mg Levofloxacin (as levofloxacin hemihydrate).
Livador® 750 Film Coated Tablets: Packs of 5 tablets (one bilster). Each tablet contains 750 mg Levofloxacin (as levofloxacin hemihydrate).
Not all pack sizes may be marketed. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment CO. LTD. (Na&#39;ur &minus; Jordan).</p><p>Tel. (+962 6) 57 27 132</p><p>Fax. (+962 6) 57 27 776</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ما هي </strong><strong>أقراص ليفادور</strong></p><p>إن اسم دواءك هو أقراص <strong>ليفادور</strong>. إن أقراص <strong>ليفادور</strong> تحتوي على دواء يسمى ليفوفلوكساسين. ينتمي هذا الدواء الى مجموعة من الادوية تسمى المضادات الحيوية. إن ليفوفلوكساسين هو مضاد حيوي من فئة &quot;الكوينولونات&quot;. يعمل هذا الدواء عن طريق القضاء على البكتيريا المسببة للعدوى في الجسم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ما هي دواعي إستعمال هذا الدواء</strong></p><p>تستخدم اقراص <strong>ليفادور</strong> لعلاج العدوى في:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجيوب الانفية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرئتين، في الاشخاص الذين يعانون من مشاكل طويلة الامد في التنفس أو التهاب الرئة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المسالك البولية، وتشمل الكليتين أو المثانة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غدة البروستات، في حال وجود عدوى طويلة الامد</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجلد و ما تحته، ويشمل العضلات. تسمى في بعض الاحيان &quot; النسيج الرخو&quot;</p><p>في بعض الحالات الخاصة، قد يستخدم ليفوفلوكساسين لتقليل احتمالية الاصابة بمرض في الرئة يدعى الجمرة الخبيثة او تفاقم المرض بعد التعرض للبكتيريا المسببة لمرض الجمرة الخبيثة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>موانع</strong><strong> </strong><strong>استعمال</strong><strong> </strong><strong>أقراص ليفادور</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الحساسية تجاه ليفوفلوكساسين أو أي من المضادات الحيوية من الكوينولونات مثل موكسيفلوكساسين، سيبروفلوكساسين او اوفلوكساسين، أو إلى أي من السواغ الموجودة في أقراص <strong>ليفادور</strong>. إن علامات الاصابة برد فعل تحسسي تشمل : طفح، مشاكل في البلع او التنفس، تورم في الشفاه، الوجه، الحلق او اللسان.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال حدوث اختلال في مدى النظر او حدث لديك اي اختلالات بصرية اخرى، قم باستشارة اخصائي عيون على الفور.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من الصرع.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من مشكلة في الاوتار مثل التهاب الوتر المرتبط بالعلاج بمضاد حيوي من الكوينولونات. إن الوتر هو الحبل الذي يربط العضلات مع الهيكل العظمي.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الاطفال والمراهقين.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملا ، تفكرين بالحمل أو تتوقعين الحمل.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنتِ مرضع.</p><p>لا تتناول هذا الدواء اذا انطبق عليك أي من الحالات السابقة. اذا لم تكن متأكدا، تحدث الى طبيبك او الصيدلي قبل تناول أقراص <strong>ليفادور</strong>.</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الاحتياطات عند استعمال ليفادور</strong></p><p>تحقق من الطبيب او الصيدلي قبل تناول هذا الدواء اذا:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان عمرك 60 سنة فأكثر</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تستخدم الستيرويدات القشرية، تسمى احيانا الستيرويدات</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من نوبات( صرع)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من تلف في الدماغ نتيجة لحدوث جلطة دماغية او اي اصابة اخرى في الدماغ</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من مشاكل في الكلى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من حالة تسمى &quot;نقص في الانزيم 6- فوسفات نازع الهيدروجين&quot;. فحينها تكون اكثر عرضة للاصابة بمشاكل خطيرة في الدم بالتزامن مع تناول هذا الدواء</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من مشاكل في الصحة العقلية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من مشاكل في القلب. ينبغي توخي الحذر عند استخدام هذا النوع من الادوية اذا كان لديك استطالة في فترة كيو تي او كان لديك تاريخ عائلي لهذه الحالة (يتم تشخيصها عن طريق تخطيط القلب الكهربائي) او اختلال في الاملاح في الدم (خصوصا انخفاض البوتاسيوم او المغنيسيوم في الدم) او تباطؤ شديد في نظم قلب او قصور قلبي او تاريخ لحدوث نوبة قلبية (احتشاء قلبي) او كنتِ انثى او من كبار السن او كنت تتناول ادوية اخرى تسبب تغيرات غير اعتيادية في تخطيط القلب الكهربائي.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من السكري</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا سبق وعانيت من مشاكل في الكبد</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من الوهن العضلي الوبيل (مرض نادر في الجهاز العصبي)</p><p><strong>محاذير أخرى:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يسبب ليفوفلوكساسين بشكل نادر ألم والتهاب في الاوتار. خصوصا اذا كنت من كبار السن او كنت تتناول ادوية الستيرويدات (مثل كورتيزون او هيدروكورتيزون). اذا كان لديك اي مشاكل اخرى في الاوتار اثناء او بعد فترة قصيرة من تناول ليفوفلوكساسين، اطلب الاستشارة الطبية على الفور وأرح الاطراف المصابة (الساق او الذراع). لا تتناول الجرعة التالية من ليفوفلوكساسين ما لم يخبرك الطبيب بذلك. في مثل هذه الحالات، قد تشعر بورم او ألم في مكان الوتر المصاب. قد يكون وقف العلاج ضروريا.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال بداية حدوث إسهال شديد ومطول و/او دموي خلال او بعد العلاج بليفوفلوكساسين، أخبر طبيبك على الفور. قد يعني هذا أنك تعاني من التهاب خطير في الامعاء (التهاب القولون الغشائي الكاذب)، والتي قد تحدث احيانا بعد العلاج بالمضادات الحيوية. قد تحتاج الى وقف العلاج بليفوفلوكساسين ومتابعة طبيبك ليصف لك دواء آخر.&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اثناء العلاج بليفوفلوكساسين، يُنصح بالابتعاد عن اشعة الشمس القوية وعدم استخدام المصابيح الشمسية. لأن بعض المرضى قد يصبحوا اكثر حساسية للضوء اثناء استخدام ليفوفلوكساسين والاصابة برد فعل تحسسي شبيه بحرق الشمس.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب وقف العلاج بليفوفلوكساسين اذا شعر المريض بأعراض لسع، وخز، ألم او خدران. قد تكون هذه علامات على حدوث ما يعرف ب&quot;الاعتلال العصبي&quot;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يعد ليفوفلوكساسين علاجا مناسبا لمعظم الحالات الشديدة جدا من التهاب الرئة الذي تسببه بكتيريا المكورات الرئوية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحتاج العدوى التي تصيب المريض داخل المستشفى والتي تسببها بكتيريا السودوموناس ايروجينوسا (الزائفة الزنجارية) الى علاج مركب.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ان ليفوفلوكساسين غير فعال في علاج العدوى التي تسببها بكتيريا المكورات العنقودية المقاومة للميثيسيلين. في العدوى التي يشتبه انها البكتيريا المسببة، فإنه يجب اخذ ليفوفلوكساسين مع علاج اخر من المعروف انه يعالج العدوى التي تسببها بكتيريا المكورات العنقودية المقاومة للميثيسيلين.</p><p>اذا لم تكن متأكدا من انطباق أي من الحالات السابقة عليك، تحدث الى طبيبك او الصيدلي قبل تناول أقراص <strong>ليفادور</strong>.</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أخذ</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>غذائية</strong></p><p>أخبر طبيبك أو الصيدلي اذا كنت تتناول او سبق وتناولت اي أدوية أخرى. لأن أقراص <strong>ليفادور</strong> قد تؤثر على الآلية التي تعمل بها بعض الادوية. كما قد تؤثر بعض الادوية على آلية عمل أقراص <strong>ليفادور</strong>.</p><p>على وجه الخصوص، أخبر طبيبك اذا كنت تتناول أي من الادوية التالية. وهذا لأنه من الممكن أن تزيد فرصة حدوث الأعراض الجانبية بالتزامن مع تناول <strong>ليفادور</strong>:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الستيرويدات القشرية، تسمى أحيانا الستيرويدات &ndash; تستخدم لعلاج الالتهاب. قد تصبح أكثر عرضة لحدوث التهاب و/أو تمزق في الاوتار</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الورفارين- يستخدم كمميع للدم. قد تصبح أكثر عرضة لحدوث نزيف. قد يطلب طبيبك منك القيام بفحوصات دم منتظمة للتحقق من قدرة دمك على التجلط بشكل مناسب.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الثيوفيللين- يستخدم في علاج مشاكل التنفس. قد تصبح اكثر عرضة للنوبات (إختلاجات) بالتزامن مع تناول ليفوفلوكساسين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية غير الستيرويدية المضادة للالتهاب- التي تستخدم لعلاج الالم والالتهاب مثل الاسبرين، الايبوبروفين ، فينبيوفين، كيتوبروفين و اندوميثاسين. قد تصبح اكثر عرضة للنوبات (إختلاجات) بالتزامن مع تناول ليفوفلوكساسين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السيكلوسبورين- يستخدم بعد نقل الاعضاء. قد تصبح اكثر عرضة للاصابة بالاعراض الجانبية لسيكلوسبورين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية التي من المعروف انها تؤثر على ضربات القلب. وهذا يشمل الادوية التي تستخدم لعلاج ضربات القلب غير المنتظمة (مضادات اضطراب النظم مثل كوينيدين و اميودارون)، للاكتئاب (مضادات الاكتئاب ثلاثية الحلقات مثل اميتريبتيلين و اميبرامين) و للعدوى البكتيرية (المضادات الحيوية من فئة الماكروليدات مثل اريثروميسين، ازيثروميسين و كلاريثروميسين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بروبينسيد &ndash; تستخدم في علاج النقرس والسيميتيدين &ndash; الذي يستخدم لعلاج القرحة وحرقة المعدة. يجب ان يكون هناك اهتمام خاص عند تناول اي من هذه الادوية بالتزامن مع ليفوفلوكساسين. اذا كنت تعاني من مشاكل في الكلى، قد يحدد لك الطبيب جرعة أقل.</p><p>لا تتناول أقراص <strong>ليفادور</strong> بالتزامن مع الادوية التالية. لانها قد تؤثر على طريقة عمل ليفوفلوكساسين:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص الحديد (لفقر الدم)، المكملات الغذائية المحتوية على الزنك، مضادات الحموضة المحتوية على المغنيسيوم او الالومنيوم (للحموضة أو حرقة المعدة)، ديدانوسين أو سوكرالفات (لقرحة المعدة)</p><p><u>فحوصات البول للكشف عن الافيونات</u></p><p>قد تظهر فحوصات البول نتائج &quot; ايجابية كاذبة&quot; للمسكنات القوية المدعوة الافيونات في الاشخاص الذين يتناولون ليفوفلوكساسين. اذا طلب الطبيب منك القيام بفحص للبول، اخبره بأنك تتناول أقراص <strong>ليفادور</strong>.</p><p><u>فحوصات الكشف عن السل</u></p><p>يسبب هذا الدواء نتائج &quot;سلبية كاذبة&quot; في بعض الفحوصات المخبرية للكشف عن البكتيريا المسببة للسل.</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>تناول أقراص ليفادور مع الطعام والشراب</strong></p><p>تناول الدواء بغض النظر عن الوجبات. تناول الدواء مع كمية وافرة من الماء. قد يسبب تناول الدواء مع عصير البرتقال الى انخفاض مستويات الكوينولونات في البلازما.</p><p><strong>&nbsp;</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الحمل والرضاعة</strong></p><p>لا تتناول أقراص <strong>ليفادور</strong> في حال:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنتِ حامل، تتوقعين الحمل او تخططين للحمل</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنتِ مرضع او تخططين للارضاع</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>تأثير </strong><strong>أقراص ليفادور</strong><strong> على القيادة واستخدام الآلات </strong></p><p>قد تظهر لديك أعراض جانبية بعد تناول هذا الدواء، تشمل الشعور بالدوار، النعاس، شعور بالوخز (دوخة) او تغيرات في الرؤية. قد تؤثر بعض هذه الاعراض الجانبية على قدرتك على التركيز وسرعة الاستجابة. اذا حدث لك هذا، لا تقم بالقيادة أو تقوم بأعمال تحتاج لاهتمام خاص.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول أقراص <strong>ليفادور</strong> دائما كما أخبرك الطبيب. عليك التحقق مع طبيبك او الصيدلي اذا لم تكن متأكدا.</p><p><strong>استخدام هذا الدواء: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تناول هذا الدواء عن طريق الفم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إبلع الأقراص كاملة مع الماء.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; يمكن تناول الأقراص خلال وجبة الطعام أو في أي وقت بين الوجبات.</p><p><strong>يجب أن تحمي جلدك من أشعة الشمس. </strong></p><p>يجب أن تتجنب التعرض المباشر لأشعة الشمس خلال تناول هذا الدواء. لأن جلدك سوف يصبح أكثر حساسية تجاه أشعة الشمس ومن الممكن أن يتسبب بحدوث حروق، وخز، أو نفطات شديدة إذا لم تقم بإتخاذ الإحتياطات التالية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من إستخدام كريم واقٍ من الشمس بحماية عالية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إرتداء قبعة و ملابس تغطي كل من اليدين أو القدمين</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجنب إستخدام الأسرة الشمسية</p><p><strong>في حال كنت تتناول أقراص تحتوي على الحديد، </strong><strong>مضادات الحموضة أو سوكرالفات </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمنع تناول هذه الأدوية بالتزامن مع <strong>ليفادور</strong> بنفس الوقت. يجب أن تفصل بين هذه الأدوية و<strong>ليفادور</strong> بمدة زمنية لا تقل عن ساعتين.</p><p><strong>الجرعة اليومية </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يقرر طبيبك الجرعة التي يجب أن تقوم بتناولها.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعتمد الجرعة على طبيعة العدوى ومكان العدوى في جسمك.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعتمد فترة العلاج على خطورة العدوى.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا شعرت أن تأثير هذا الدواء قوي أو ضعيف جدا، لا تغير الجرعة من تلقاء نفسك وإستشر طبيبك.</p><p><strong><u>البالغين وكبار السن: </u></strong></p><p><strong>عدوى </strong><strong>الجيوب الأنفية</strong>: تناول قرصين من <strong>ليفادور</strong> 250 ملغم مرة واحدة يوميا، أو قرص واحد من <strong>ليفادور</strong> 500 ملغم أو 750 ملغم مرة واحدة يوميا.</p><p><strong>عدوى الرئتين، في الأشخاص الذين يعانون من مشاكل في التنفس طويلة الامد</strong>: قرصين من <strong>ليفادور</strong> 250 مرة واحدة يوميا، أو قرص واحد من <strong>ليفادور</strong>500 ملغم مرة واحدة يوميا.</p><p><strong>الإلتهاب الرئوي</strong>: قرصين من <strong>ليفادور</strong> 250 ملغم مرة واحدة أو مرتين يوميا أو <strong>ليفادور</strong> 500 ملغم مرة واحدة أو مرتين يوميا، أو قرص واحد من <strong>ليفادور</strong> 750 مرة واحدة يوميا.</p><p><strong>عدوى المسالك البولية تتضمن الكليتين أو المثانة</strong>: قرص واحد او قرصين من <strong>ليفادور</strong> 250 ملغم مرة واحدة يوميا، او نصف قرص او قرص واحد من <strong>ليفادور</strong> 500 ملغم مرة واحدة يوميا او قرص واحد من <strong>ليفادور</strong> 750 ملغم مرة واحدة يوميا. &nbsp;&nbsp;</p><p><strong>عدوى في غدة البروستات</strong>: قرصين من <strong>ليفادور</strong> 250 ملغم مرة واحدة يوميا، أو قرص واحد من <strong>ليفادور</strong> 500 ملغم مرة واحدة يوميا.</p><p><strong>عدوى الجلد و ما تحت الجلد، بما في ذلك العضلات</strong>: قرصين من <strong>ليفادور</strong> 250<strong> </strong>مرة واحدة أو مرتين يوميا، أو قرص واحد من <strong>ليفادور</strong> 500 ملغم مرة واحدة يوميا أو مرتين يوميا أو قرص واحد من <strong>ليفادور</strong> 750 مرة واحدة يوميا.</p><p><strong>الجمرة الخبيثة عن طريق الاستنشاق: </strong>قرصين من <strong>ليفادور</strong> 250 ملغم مرة واحدة يوميا، أو قرص واحد من <strong>ليفادور</strong> 500 ملغم مرة واحدة يوميا.</p><p><strong><u>البالغين وكبار السن الذين يعانون من مشاكل في الكلية</u></strong><u>: </u></p><p>قد يقوم طبيبك بإعطائك جرعة أقل.</p><p><strong><u>الأطفال والمراهقين</u></strong></p><p>يمنع إعطاء هذا الدواء للأطفال او المراهقين.</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من</strong><strong> اقراص</strong><strong> </strong><strong>ليفادور</strong></p><p>إذا قمت بتناول أكثر من الجرعة الموصوفة عن طريق الخطأ. أخبر طبيبك &nbsp;أو اطلب إستشارة طبية على الفور. أظهر العبوة لطبيبك لكي يتمكن من معرفة الدواء الذي قمت بتناوله. من الممكن حدوث الاعراض التالية: نوبات تشنج، الشعور بإرتباك، دوار، إنخفاض في الوعي، رعشة ومشاكل في القلب من الممكن أن تؤدي إلى ضربات قلب متفاوتة بالإضافة إلى حدوث غثيان او حرقة في المعدة. &nbsp;</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>نسيان</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>جرعة</strong><strong> من اقراص </strong><strong>&nbsp;</strong><strong>ليفادور</strong></p><p>إذا نسيت تناول جرعة، تناول الجرعة فور تذكرها إلا إذا كان ذلك قريبا من الجرعة التي تليها. لا تضاعف الجرعة للتعويض عن الجرعة الفائتة.</p><p>&nbsp;</p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>التوقف عن تناول أقراص </strong><strong>ليفادور</strong></p><p>لا تتوقف عن تناول اقراص<strong> ليفادور</strong> إذا شعرت بتحسن. يجب أن تقوم بإنهاء العلاج الذي قام طبيبك بتحديده. إذا توقفت عن تناول الدواء بشكل مبكر من الممكن أن تحدث العدوى مرة أخرى وبشكل أسوأ أو قد تحدث مقاومة تجاه هذا الدواء.</p><p>إذا كانت لديك أي أسئلة أخرى تتعلق بهذا الدواء، إستشر طبيبك أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن الأدوية الأخرى من الممكن أن يسبب <strong>ليفادور</strong> أعراضا جانبية على الرغم من عدم حدوثها مع جميع المرضى.</p><p><strong>توقف عن تناول الدواء وإستشر طبيبك أو توجه إلى أقرب مستشفى على الفور إذا لاحظت حدوث الأعراض الجانبية التالية: </strong></p><p><strong>نادر جدا (تؤثر في أقل من شخص واحد في كل 10000) </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا حدث لديك تفاعلات حساسية. من الممكن أن تتضمن العلامات حدوث: طفح، تورم أو مشاكل في التنفس، تورم الشفاه، الوجه، الحلق أو اللسان.</p><p><strong>توقف عن تناول الدواء وإستشر طبيبك على الفور إذا لاحظت حدوث الأعراض الجانبية الشديدة التالية &ndash; من الممكن أن تحتاج إلى الرعاية الطبية الفورية: </strong></p><p><strong>نادر (تؤثر في أقل من شخص واحد في كل 1000)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إسهال مائي والذي من الممكن أن يحتوي على دم، قد يصاحبه تقلصات في المعدة وإرتفاع في درجة الحرارة. يمكن أن تكون هذه علامات على وجود مشكلة خطيرة في الأمعاء.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ألم وإلتهاب في الأوتار او الاربطة، والذي قد يؤدي الى تمزق. قد يتأثر وتر العرقوب وفي بعض الأحيان من الممكن أن يحدث كسر في الوتر.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; نوبات (تشنجات)</p><p><strong>نادر جدا (تؤثر في أقل من شخص واحد في كل 10000)</strong></p><p><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </em>حرق، وخز، ألم أو تنميل. قد تكون هذه علامات حدوث ما يسمى &quot;بالإعتلال العصبي&quot;</p><p><strong>غير معروف (لا يمكن تقدير معدل التكرار من البيانات المتاحة)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي شديد قد يتضمن حدوث تقرحات أو تقشر في الجلد حول الشفاه، العينين، الفم، الأنف والأعضاء التناسلية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية، إصفرار الجلد والعينين، بول داكن ، حكة، أو ألم عند اللمس في المعدة (البطن). قد تكون هذه علامات حدوث مشاكل في الكبد والذي قد يؤدي الى قصور كبدي مميت.</p><p>في حال حدوث اختلال في مدى النظر او حدث لديك اي اختلالات بصرية اخرى اثناء تناول ليفوفلوكساسين، قم باستشارة اخصائي عيون على الفور.</p><p><strong>أخبر طبيبك إذا حدثت أي من الأعراض الجانبية التالية بشكل خطير أو إستمرت لفترة تزيد عن بضعة أيام :</strong></p><p><strong>شائع (تؤثر في أقل من شخص واحد في كل 10)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النوم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; صداع، الشعور بالدوار</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; غثيان وتقيؤ وإسهال</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستوى بعض إنزيمات الكبد في الدم</p><p><strong>غير شائع (تؤثر في أقل من شخص واحد في كل 100)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيير في عدد البكتيريا الأخرى أو زيادة الفطريات، والتي تسمى المبيضات والتي قد تحتاج إلى العلاج</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغير في عدد خلايا الدم البيضاء تظهر في نتائج بعض إختبارات الدم (نقص الكريات البيض، فرط الحمضات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالقلق، ارتباك، عصبية، نعاس، تهيج أو دوار</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في التنفس</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في التذوق، فقدان الشهية، إضطراب في المعدة أو عسر الهضم، قيء أو ألم في منطقة المعدة، الشعور بإنتفاخ أو إمساك</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; حكة وطفح جلدي، حكة شديدة او شرى (ارتيكاريا)، التعرق المفرط</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في المفاصل أو العضلات</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; قد تظهر إختبارات الدم نتائج غير إعتيادية بسبب حدوث مشاكل في الكبد (ارتفاع البيليروبين) أو الكلى (ارتفاع الكرياتنين)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ضعف عام</p><p><strong>نادر (تؤثر في أقل من شخص واحد في كل 1000) </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سهولة حدوث كدمات ونزف بسهولة بسبب إنخفاض عدد الصفائح الدموية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض عدد خلايا الدم البيضاء (وتسمى العدلات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; فرط إستجابة جهاز المناعة (فرط الحساسية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض مستوى السكر في الدم (نقص سكر الدم). يعد هذا مهم في الأشخاص الذين يعانون من مرض السكري</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; رؤية أو سماع أشياء غير موجودة (هلوسات، جنون العظمة)، تغير في الآراء والأفكار (تفاعلات ذهانية) مع إحتمالية حدوث أفكار أو أفعال انتحارية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور باكتئاب، مشاكل عقلية، الشعور بتهيج، احلام غير اعتيادية او كوابيس</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بوخز في اليدين والقدمين (خدران) &nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في السمع (طنين الاذن) او البصر ( تشوش الرؤية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع في ضربات القلب غير إعتيادي أو إنخفاض ضغط الدم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ضعف في العضلات. يعد ذلك مهما في الأشخاص الذين يعانون من الوهن العضلي (مرض نادر في الجهاز العصبي)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في آلية عمل الكلية أو فشل متقطع في الكلية والتي من الممكن أن تكون ناتجة عن تفاعلات حساسية في الكلية تسمى بإلتهاب الكلية الخلالي.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى</p><p><strong>غير معروف (لا يمكن تقدير معدل التكرار من البيانات المتاحة)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض عدد خلايا الدم الحمراء (فقر دم): من الممكن أن يسبب ذلك شحوب البشرة أو إصفرار نتيجة تلف خلايا الدم الحمراء وإنخفاض عدد جميع أنواع خلايا الدم.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; حمى، ألم في الحلق وشعور عام بتوعك لا يتحسن مع الوقت قد يكون نتيجة حدوث إنخفاض في عدد خلايا الدم البيضاء.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; نقص الدورة الدموية (شبيهة بالصدمة التأقية)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات السكر في الدم او انخفاض مستويات السكر في الدم (غيبوبة ناتجة عن نقص السكر). يعد هذا الامر مهما في مرضى السكري</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الشم، فقدان الشم او التذوق او اختلال البصر</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الحركة والمشي ( تشنجات، اضطرابات خارج السبيل الهرمي)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان مؤقت في الوعي او وضع الجسد (اغماء)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان مفاجئ في الرؤية، التهاب العين</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلال او فقدان السمع</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع غير اعتيادي في ضربات القلب، نظم قلب غير منتظم قد يهدد الحياة ويشمل سكتة قلبية، اختلال في نظم القلب (يسمى استطالة فترة - كيو تي والتي يتم ملاحظتها في تخطيط القلب الكهربائي، التوصيل الكهربائي للقلب)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس او صفير (تشنج قصبي)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;تفاعلات حساسية في الرئة</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة حساسية بشرتك لأشعة الشمس والأشعة فوق البنفسجية</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب في الأوعية التي تحمل الدم حول الجسم نتيجة حدوث تفاعلات حساسية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الانسجة داخل الفم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تمزق عضلي وتدمير عضلي (انحلال الريبيدات)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار في المفاصل وتورم (التهاب مفاصل)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم، يتضمن حدوث ألم في الظهر، الصدر والأطراف</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; نوبات فرفرية في الأشخاص الذين يعانون مسبقا من فرفرية (مرض نادر في التمثيل الغذائي)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; صداع دائم مع او بدون تشوش في الرؤية (ارتفاع ضغط الدم داخل الجمجمة حميد)</p><p>إذا حدثت أي من الأعراض الجانبية بشكل شديد، أو إذا لاحظت أي اعراض جانبية لم يتم ذكرها في هذه النشرة، أخبر طبيبك أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي الاطفال و نظرهم.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ دون 30 درجة مئوية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول <strong>&nbsp;ليفادور</strong> بعد تاريخ الانتهاء المذكور على العبوة الخارجية. يدل تاريخ الانتهاء على آخر يوم في الشهر المذكور.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الادوية في المياه العادمة او النفايات المنزلية. اسأل الصيدلي حول الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ما هي محتويا</strong><strong>ت</strong><strong>&nbsp; ليفادور&nbsp; </strong></p><p>يتوافر<strong> ليفادور </strong>في تراكيز تحتوي<strong> </strong>على 250، 500 أو 750 من المادة الفعالة، ليفوفلوكساسين (على هيئة هيميهيدرات الليفوفلوكساسين).</p><p>المكونات الأخرى هي كروس بوفيدون، سيليلوز دقيق البلورية، صوديوم ستيرايل فيومارات، هيبروميلوز، تالك، لون أصفر (E172)، لون أحمر (E172)، اوبادراي (هيبروميلوز، ثاني أكسيد التيتانيوم، ماكروغول).</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ما هو الشكل الصيدلاني لأقراص ليفادور</strong></p><p>أقراص <strong>ليفادور 250 المغلفة </strong>هي أقراص مغلفة لونها وردي فاتح ، مستطيلة الشكل مع قطع عرضي على الجهتين، مرمزة بالرمز (MAT250 ) عاى جهة واحدة ، ملساء على الجهة الاخرى.</p><p>أقراص <strong>ليفادور 500 المغلفة </strong>هي أقراص مغلفة لونها وردي فاتح ، مستطيلة الشكل مع قطع عرضي على الجهتين، مرمزة بالرمز (MAT500 ) عاى جهة واحدة ، ملساء على الجهة الاخرى.</p><p>أقراص <strong>ليفادور 750 المغلفة </strong>هي أقراص مغلفة لونها وردي فاتح ، بيضاوية الشكل ، مرمزة بالرمز (MAT750 ) على جهة واحدة ، ملساء على الجهة الاخرى.</p><p><strong>&nbsp;</strong></p><p><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>محتويات عبوة أقراص ليفادور </strong></p><p><strong>ليفادور</strong> أقراص مغلفة داخل أشرطة من الألمنيوم.</p><p><strong>ليفادور 250 أقراص مغلفة</strong>: تتوافر في حزم من 7 أقراص (شريط واحد) و 350 قرص (50 شريط). يحتوي كل قرص على 250 ملغم من ليفوفلوكساسين (على هيئة هيميهيدرات&nbsp; الليفوفلوكساسين)</p><p><strong>ليفادور 500 أقراص مغلفة</strong>: تتوافر في حزم من 7 أقراص (شريط واحد) و 350 قرص (50 شريط). يحتوي كل قرص على 500 ملغم من ليفوفلوكساسين (على هيئة هيميهيدرات&nbsp; الليفوفلوكساسين)</p><p><strong>ليفادور 750 أقراص مغلفة</strong>: تتوافر في حزم من 5 أقراص (شريط واحد)، يحتوي كل قرص على 750 ملغم من ليفوفلوكساسين ( على هيئة هيميهيدرات&nbsp; الليفوفلوكساسين).</p><p>قد لا يتم تسويق جميع العبوات.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة (ناعور - الأردن)</p><p>هاتف. 132 27 57 (6 962 +)</p><p>فاكس.776 27 57 (6 962 +)</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Livador® 250mg Film Coated Tablets.
Livador® 500mg Film Coated Tablets.
Livador® 750mg Film Coated Tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Livador 250mg Film coated Tablets: Each tablet contains 250 mg of levofloxacin as levofloxacin hemihydrate.
Livador 500mg Film Coated Tablets: Each tablet contains 500 mg of levofloxacin as levofloxacin hemihydrate.
Livador 750mg Film Coated Tablets: Each tablet contains 750 mg of levofloxacin as levofloxacin hemihydrate.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Livador® 250 Film Coated Tablets are light pink, oblong shaped film coated tablets with a mid-groove on both sides, coded (MAT250) on one side, plain on the other side.
Livador® 500 Film Coated Tablets are light pink, oblong shaped film coated tablets with a mid-groove on both sides, coded (MAT500) on one side, plain on the other side.
Livador® 750 Film Coated Tablets are light pink, oval normal biconvex film coated tablets coded (MAT750) on one side, plain on the other side.
  

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Livador &nbsp;is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1):</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute bacterial sinusitis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute exacerbations of chronic bronchitis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Community-acquired pneumonia</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Complicated skin and soft tissue infections</p><p>For the above-mentioned infections Livador &nbsp;should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pyelonephritis and complicated urinary tract infections (see section 4.4)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chronic bacterial prostatitis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncomplicated cystitis (see section 4.4)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inhalation Anthrax: post exposure prophylaxis and curative treatment (see section 4.4)</p><p>Livador may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.</p><p>&nbsp;</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Livador tablets are administered once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.</p><p>Livador tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin; given the bioequivalence of the parenteral and oral forms, the same dosage can be used.</p><p>Posology</p><p>The following dose recommendations can be given for Livador:</p><p>Dosage in patients with normal renal function (creatinine clearance &gt; 50 ml/min)</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p>Indication</p></td><td style="vertical-align:top"><p>Daily dose regimen</p><p>(according to severity)</p></td><td style="vertical-align:top"><p>Duration of treatment</p><p>(according to severity)</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Acute bacterial sinusitis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>10 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>5 days</p></td></tr><tr><td style="vertical-align:top"><p>Acute bacterial exacerbations of chronic bronchitis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 - 10 days</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Community-acquired pneumonia</p></td><td style="vertical-align:top"><p>500 mg once or twice daily</p></td><td style="vertical-align:top"><p>7 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>5 days</p></td></tr><tr><td style="vertical-align:top"><p>Nosocomial Pneumonia</p></td><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>7-14 days</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Pyelonephritis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 - 10 days</p></td></tr><tr><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>5 days</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Complicated urinary tract infections</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 &ndash; 14 days</p></td></tr><tr><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>5 days</p></td></tr><tr><td style="vertical-align:top"><p>Uncomplicated cystitis</p></td><td style="vertical-align:top"><p>250mg once daily</p></td><td style="vertical-align:top"><p>3 days</p></td></tr><tr><td style="vertical-align:top"><p>Chronic bacterial prostatitis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>28 days</p></td></tr><tr><td style="vertical-align:top"><p>Complicated skin and soft tissue infections</p></td><td style="vertical-align:top"><p>500 mg once or twice daily</p></td><td style="vertical-align:top"><p>7 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Complicaled skin amd skin structure infections (SSSI)</p></td><td style="vertical-align:top"><p>750 mg once daily</p></td><td style="vertical-align:top"><p>7-14 days</p></td></tr><tr><td style="vertical-align:top"><p>Inhalation Anthrax</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>8 weeks</p></td></tr></tbody></table><p>Special populations</p><p>Impaired renal function (creatinine clearance &le; 50 ml/min)</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p>Dose regimen</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>250 mg/24 h</p></td><td style="vertical-align:top"><p>500 mg/24 h</p></td><td style="vertical-align:top"><p>500 mg/12 h</p></td></tr><tr><td style="vertical-align:top"><p>Creatinine clearance</p></td><td style="vertical-align:top"><p>first dose: 250 mg</p></td><td style="vertical-align:top"><p>first dose: 500 mg</p></td><td style="vertical-align:top"><p>first dose: 500 mg</p></td></tr><tr><td style="vertical-align:top"><p>50-20 ml/min</p></td><td style="vertical-align:top"><p>then: 125 mg/24 h</p></td><td style="vertical-align:top"><p>then: 250 mg/24 h</p></td><td style="vertical-align:top"><p>then: 250 mg/12 h</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>19-10 ml/min</p></td><td style="vertical-align:top"><p>then: 125 mg/48 h</p></td><td style="vertical-align:top"><p>then: 125 mg/24 h</p></td><td style="vertical-align:top"><p>then: 125 mg/12 h</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 10 ml/min (including haemodialysis and CAPD) <sup>1</sup></p></td><td style="vertical-align:top"><p>then: 125 mg/48 h</p></td><td style="vertical-align:top"><p>then: 125 mg/24 h</p></td><td style="vertical-align:top"><p>then: 125 mg/24 h</p></td></tr></tbody></table><p><sup>1</sup> No additional doses are required after haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).</p><p>Impaired liver function</p><p>No adjustment of dose is required since levofloxacin is not metabolised to any relevant extent by the liver and is mainly excreted by the kidneys.</p><p>Elderly Population</p><p>No adjustment of dose is required in the elderly, other than that imposed by consideration of renal function (See section 4.4 &ldquo;Tendinitis and tendon rupture&rdquo; and &ldquo;QT interval prolongation&rdquo;).</p><p>Paediatric population</p><p>Livador is contraindicated in children and growing adolescents (see section 4.3).</p><p>Method of administration</p><p>Livador tablets should be swallowed without crushing and with sufficient amount of liquid. They may be divided at the score line to adapt the dose. The tablets may be taken during meals or between meals. Livador tablets should be taken at least two hours before or after iron salts, zinc salts, magnesium- or aluminium-containing antacids, or didanosine (only didanosine formulations with aluminium or magnesium containing buffering agents), and sucralfate administration, since reduction of absorption can occur (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Levofloxacin tablets must not be used:
•	in patients hypersensitive to levofloxacin or other quinolones or any of the excipients listed in section 6.1
•	in patients with epilepsy,
•	in patients with history of tendon disorders related to fluoroquinolone administration,
•	in children or growing adolescents,
•	during pregnancy,
•	in breast-feeding women.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methicillin-resistant <em>S. aureus </em>are very likely to possess co-resistance to fluoroquinolones, including levofloxacin. Therefore levofloxacin is not recommended for the treatment of known or suspected MRSA infections unless laboratory results have confirmed susceptibility of the organism to levofloxacin (and commonly recommended antibacterial agents for the treatment of MRSA-infections are considered inappropriate).</p><p>Levofloxacin may be used in the treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.</p><p>Resistance to fluoroquinolones of <em>E. coli </em>&ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in <em>E. coli </em>to fluoroquinolones.</p><p>Inhalation Anthrax: Use in human is based on <em>in vitro Bacillus anthracis </em>susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.</p><p><em>Tendinitis and tendon rupture</em></p><p>Tendinitis may rarely occur. It most frequently involves the Achilles tendon and may lead to tendon rupture. Tendinitis and tendon rupture, sometimes bilateral, may occur within 48 hours of starting treatment with levofloxacin and have been reported up to several months after discontinuation of treatment. The risk of tendinitis and tendon rupture is increased in patients aged over 60 years, in patients receiving daily doses of 1000 mg and in patients using corticosteroids. The daily dose should be adjusted in elderly patients based on creatinine clearance (see section 4.2). Close monitoring of these patients is therefore necessary if they are prescribed levofloxacin. All patients should consult their physician if they experience symptoms of tendinitis. If tendinitis is suspected, treatment with levofloxacin must be halted immediately, and appropriate treatment (e.g. immobilisation) must be initiated for the affected tendon (see sections 4.3 and 4.8).</p><p><em>Clostridium difficile-associated disease</em></p><p>Diarrhoea, particularly if severe, persistent and/or bloody, during or after treatment with levofloxacin (including several weeks after treatment), may be symptomatic of <em>Clostridium difficile</em>-associated disease (CDAD). CDAD may range in severity from mild to life threatening, the most severe form of which is pseudomembranous colitis (see section 4.8). It is therefore important to consider this diagnosis in patients who develop serious diarrhoea during or after treatment with levofloxacin. If CDAD is suspected or confirmed, levofloxacin should be stopped immediately and appropriate treatment initiated without delay. Anti-peristaltic medicinal products are contraindicated in this clinical situation.</p><p><em>Patients predisposed to seizures</em></p><p>Quinolones may lower the seizure threshold and may trigger seizures. Levofloxacin is contraindicated in patients with a history of epilepsy (see section 4.3) and, as with other quinolones, should be used with extreme caution in patients predisposed to seizures or concomitant treatment with active substances that lower the cerebral seizure threshold, such as theophylline (see section 4.5). In case of convulsive seizures (see section 4.8), treatment with levofloxacin should be discontinued.</p><p><em>Patients with G-6- phosphate dehydrogenase deficiency </em></p><p>Patients with latent or actual defects in glucose-6-phosphate dehydrogenase activity may be prone to haemolytic reactions when treated with quinolone antibacterial agents. Therefore, if levofloxacin has to be used in these patients, potential occurrence of haemolysis should be monitored.</p><p><em>Patients with renal impairment</em></p><p>Since levofloxacin is excreted mainly by the kidneys, the dose of Livador should be adjusted in patients with renal impairment (see section 4.2).</p><p><em>Hypersensitivity reactions </em></p><p>Levofloxacin can cause serious, potentially fatal hypersensitivity reactions (e.g. angioedema up to anaphylactic shock), occasionally following the initial dose (see section 4.8). Patients should discontinue treatment immediately and contact their physician or an emergency physician, who will initiate appropriate emergency measures.</p><p><em>Severe bullous reactions</em></p><p>Cases of severe bullous skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis have been reported with levofloxacin (see section 4.8). Patients should be advised to contact their doctor immediately prior to continuing treatment if skin and/or mucosal reactions occur.</p><p><em>Dysglycaemia</em></p><p>As with all quinolones, disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia have been reported, usually in diabetic patients receiving concomitant treatment with an oral hypoglycaemic agent (e.g., glibenclamide) or with insulin. Cases of hypoglycaemic coma have been reported. In diabetic patients, careful monitoring of blood glucose is recommended (see section 4.8).</p><p><em>Prevention of photosensitisation</em></p><p>Photosensitisation has been reported with levofloxacin (see section 4.8). It is recommended that patients should not expose themselves unnecessarily to strong sunlight or to artificial UV rays (e.g. sunray lamp, solarium), during treatment and for 48 hours following treatment discontinuation in order to prevent photosensitisation.</p><p><em>Patients treated with Vitamin K antagonists</em></p><p>Due to possible increase in coagulation tests (PT/INR) and/or bleeding in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin), coagulation tests should be monitored when these drugs are given concomitantly (see section 4.5).</p><p><em>Psychotic reactions</em></p><p>Psychotic reactions have been reported in patients receiving quinolones, including levofloxacin. In very rare cases these have progressed to suicidal thoughts and self-endangering behaviour- sometimes after only a single dose of levofloxacin (see section 4.8). In the event that the patient develops these reactions, levofloxacin should be discontinued and appropriate measures instituted. Caution is recommended if levofloxacin is to be used in psychotic patients or in patients with history of psychiatric disease.</p><p><em>QT interval prolongation</em></p><p>Caution should be taken when using fluoroquinolones, including levofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:</p><p>- congenital long QT syndrome</p><p>- concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics).</p><p>- uncorrected electrolyte imbalance (e.g. hypokalemia, hypomagnesemia)</p><p>- cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)</p><p>Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including levofloxacin, in these populations. (See sections 4.2 <em>Elderl</em>y, 4.5, 4.8, and 4.9).</p><p><em>Peripheral neuropathy</em></p><p>Peripheral sensory neuropathy and peripheral sensory motor neuropathy have been reported in patients receiving fluoroquinolones, including levofloxacin, which can be rapid in its onset (see section 4.8). Levofloxacin should be discontinued if the patient experiences symptoms of neuropathy in order to prevent the development of an irreversible condition.</p><p><em>Hepatobiliary disorders</em></p><p>Cases of hepatic necrosis up to fatal hepatic failure have been reported with levofloxacin, primarily in patients with severe underlying diseases, e.g. sepsis (see section 4.8). Patients should be advised to stop treatment and contact their doctor if signs and symptoms of hepatic disease develop such as anorexia, jaundice, dark urine, pruritus or tender abdomen.</p><p><em>Exacerbation of myasthenia gravis</em></p><p>Fluoroquinolones, including levofloxacin, have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Postmarketing serious adverse reactions, including deaths and the requirement for respiratory support, have been associated with fluoroquinolone use in patients with myasthenia gravis. Levofloxacin is not recommended in patients with a known history of myasthenia gravis.</p><p><em>Vision disorders</em></p><p>If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately (see sections 4.7 and 4.8).</p><p><em>Superinfection</em></p><p>The use of levofloxacin, especially if prolonged, may result in overgrowth of non-susceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken.</p><p><em>Interference with laboratory tests</em></p><p>In patients treated with levofloxacin, determination of opiates in urine may give false-positive results. It may be necessary to confirm positive opiate screens by more specific method.</p><p>Levofloxacin may inhibit the growth of <em>Mucobacterium tuberculosis </em>and, therefore, may give false-negative results in the bacteriological diagnosis of tuberculosis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effect of other medicinal products on Livador</u></p><p><em>Iron salts, zinc salts, magnesium- or aluminium-containing antacids, didanosine</em></p><p>Levofloxacin absorption is significantly reduced when iron salts, or magnesium- or aluminium-containing antacids, or didanosine (<em>only didanosine formulations with aluminium or magnesium containing buffering agents)</em> are administered concomitantly with Livador tablets. Concurrent administration of fluoroquinolones with multi-vitamins containing zinc appears to reduce their oral absorption. It is recommended that preparations containing divalent or trivalent cations such as iron salts, zinc salts or magnesium- or aluminium-containing antacids, or didanosine (<em>only didanosine formulations with aluminium or magnesium containing buffering agents)</em> should not be taken 2 hours before or after Livador tablet administration (see section 4.2). Calcium salts have a minimal effect on the oral absorption of levofloxacin.</p><p><em>Sucralfate</em></p><p>The bioavailability of Livador tablets is significantly reduced when administered together with sucralfate. If the patient is to receive both sucralfate and levofloxacin, it is best to administer sucralfate 2 hours after the Livador tablet administration (see section 4.2).</p><p><em>Theophylline, fenbufen or similar non-steroidal anti-inflammatory drugs</em></p><p>No pharmacokinetic interactions of levofloxacin were found with theophylline in a clinical study. However a pronounced lowering of the cerebral seizure threshold may occur when quinolones are given concurrently with theophylline, non-steroidal anti-inflammatory drugs, or other agents which lower the seizure threshold.</p><p>Levofloxacin concentrations were about 13% higher in the presence of fenbufen than when administered alone.</p><p><em>Probenecid and cimetidine</em></p><p>Probenecid and cimetidine had a statistically significant effect on the elimination of levofloxacin. The renal clearance of levofloxacin was reduced by cimetidine (24%) and probenecid (34%). This is because both drugs are capable of blocking the renal tubular secretion of levofloxacin. However, at the tested doses in the study, the statistically significant kinetic differences are unlikely to be of clinical relevance.</p><p>Caution should be exercised when levofloxacin is coadministered with drugs that affect the tubular renal secretion such as probenecid and cimetidine, especially in renally impaired patients.</p><p><em>Other relevant information</em></p><p>Clinical pharmacology studies have shown that the pharmacokinetics of levofloxacin were not affected to any clinically relevant extent when levofloxacin was administered together with the following drugs: calcium carbonate, digoxin, glibenclamide, ranitidine.</p><p><u>Effect of Livador on other medicinal products</u></p><p><em>Ciclosporin</em></p><p>The half-life of ciclosporin was increased by 33% when coadministered with levofloxacin.</p><p><em>Vitamin K antagonists</em></p><p>Increased coagulation tests (PT/INR) and/or bleeding, which may be severe, have been reported in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin). Coagulation tests, therefore, should be monitored in patients treated with vitamin K antagonists (see section 4.4).</p><p><em>Drugs known to prolong QT interval</em></p><p>Levofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics) (see section 4.4 QT interval prolongation).</p><p><em>Other relevant information</em></p><p>In a pharmacokinetic interaction study, levofloxacin did not affect the pharmacokinetics of theophylline (which is a probe substrate for CYP1A2), indicating that levofloxacin is not a CYP1A2 inhibitor.</p><p><u>Other forms of interactions</u></p><p><em>Food</em></p><p>There is no clinically relevant interaction with food. Livador tablets may therefore be administered regardless of food intake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy</em></p><p>There are limited amount of data from the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). However in the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in pregnant women (see sections 4.3 and 5.3).</p><p><em>Breast-feeding</em></p><p>Livador is contraindicated in breast-feeding women. There is insufficient information on the excretion of levofloxacin in human milk; however, other fluoroquinolones are excreted in breast milk. In the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in breast-feeding women (see sections 4.3 and 5.3).</p><p><em>Fertility</em></p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some undesirable effects (e.g. dizziness/vertigo, drowsiness, visual disturbances) may impair the patient&#39;s ability to concentrate and react, and therefore may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The information given below is based on data from clinical studies in more than 8300 patients and on extensive post marketing experience.</p><p>Frequencies are defined using the following convention: very common (&ge;1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge;1/1000, &lt;1/100), rare (&ge;1/10000, &lt;1/1000), very rare (&lt;1/10000), not known (cannot be estimated from the available data).</p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class </strong></p></td><td style="vertical-align:top"><p><strong>Common </strong></p><p><strong>(&ge;1/100 to &lt;1/10 ) </strong></p></td><td style="vertical-align:top"><p><strong>Uncommon </strong></p><p><strong>(&ge;1/1,000 to &lt;1/100) </strong></p></td><td style="vertical-align:top"><p><strong>Rare </strong></p><p><strong>(&ge;1/10,000 to &lt;1/1,000) </strong></p></td><td style="vertical-align:top"><p><strong>Not known (cannot be estimated from available data) </strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Fungal infection including Candida infection</p><p>Pathogen resistance</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Leukopenia</p><p>Eosinophilia</p></td><td style="vertical-align:top"><p>Thrombocytopenia</p><p>Neutropenia</p></td><td style="vertical-align:top"><p>Pancytopenia</p><p>Agranulocytosis</p><p>Haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Angioedema</p><p>Hypersensitivity (see section 4.4)</p></td><td style="vertical-align:top"><p>Anaphylactic shock<sup>a</sup></p><p>Anaphylactoid shock<sup>a </sup>(see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Hypoglycaemia particularly in diabetic patients (see section 4.4)</p></td><td style="vertical-align:top"><p>Hyperglycaemia</p><p>Hypoglycaemic coma (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Insomnia</p></td><td style="vertical-align:top"><p>Anxiety</p><p>Confusional state</p><p>Nervousness</p></td><td style="vertical-align:top"><p>Psychotic reactions (with e.g. hallucination, paranoia)</p><p>Depression</p><p>Agitation</p><p>Abnormal dreams</p><p>Nightmares</p></td><td style="vertical-align:top"><p>Psychotic disorders with self-endangering behaviour including suicidal ideation or suicide attempt (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache</p><p>Dizziness</p></td><td style="vertical-align:top"><p>Somnolence</p><p>Tremor</p><p>Dysgeusia</p></td><td style="vertical-align:top"><p>Convulsion (see sections 4.3 and 4.4)</p><p>Paraesthesia</p></td><td style="vertical-align:top"><p>Peripheral sensory neuropathy (see section 4.4)</p><p>Peripheral sensory motor neuropathy (see section 4.4)</p><p>Parosmia including anosmia</p><p>Dyskinesia</p><p>Extrapyramidal disorder</p><p>Ageusia</p><p>Syncope</p><p>Benign intracranial hypertension</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual disturbances such as blurred vision (see section 4.4)</p></td><td style="vertical-align:top"><p>Transient vision loss (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Ear and Labyrinth disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Vertigo</p></td><td style="vertical-align:top"><p>Tinnitus</p></td><td style="vertical-align:top"><p>Hearing loss</p><p>Hearing impaired</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Tachycardia</p><p>Palpitation</p></td><td style="vertical-align:top"><p>Ventricular tachycardia, which may result in cardiac arrest</p><p>Ventricular arrhythmia, and torsade de pointes (reported predominantly in patients with risk factors of QT prolongation), Electrocardiogram QT prolonged (see sections 4.4 and 4.9)</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p><em><u>Applies to iv form only:</u></em></p><p>Phlebitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dyspnoea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bronchospasm, Pneumonitis allergic</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Diarrhoea</p><p>Vomiting</p><p>Nausea</p></td><td style="vertical-align:top"><p>Abdominal pain</p><p>Dyspepsia</p><p>Flatulence</p><p>Constipation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diarrhoea &ndash;haemorrhagic which in very rare cases may be indicative of enterocolitis, including pseudomembranous colitis (see section 4.4)</p><p>Pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Hepatic enzyme increased (ALT/AST, alkaline phosphatase, GGT)</p></td><td style="vertical-align:top"><p>Blood bilirubin increased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Jaundice and severe liver injury, including cases with fatal acute liver failure, primarily in patients with severe underlying diseases (see section 4.4)</p><p>Hepatitis</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders<sup>b</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p><p>Urticaria</p><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p><p>Stevens-Johnson syndrome</p><p>Erythema multiforme</p><p>Photosensitivity reaction (see section 4.4)</p><p>Leukocytoclastic vasculitis</p><p>Stomatitis</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Arthralgia</p><p>Myalgia</p></td><td style="vertical-align:top"><p>Tendon disorder (see sections 4.3 and 4.4) including tendinitis (e.g. Achilles tendon)</p><p>Muscular weakness which may be of importance in patients with myasthenia gravis (see section 4.4)</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p><p>Tendon rupture (e.g. Achilles tendon) (see sections 4.3 and 4.4)</p><p>Ligament rupture</p><p>Muscle rupture</p><p>Arthritis</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Blood creatinine increased</p></td><td style="vertical-align:top"><p>Renal failure acute (e.g. due to interstitial nephritis)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p><em><u>Applies to iv form only:</u></em></p><p>Infusion site reaction (pain, reddening)</p></td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>Pain (including pain in back, chest, and extremities)</p></td></tr></tbody></table><p><sup>a</sup> Anaphylactic and anaphylactoid reactions may sometimes occur even after the first dose</p><p><sup>b</sup> Mucocutaneous reactions may sometimes occur even after the first dose</p><p>&nbsp;</p><p>Other undesirable effects which have been associated with fluoroquinolone administration include:</p><p>&nbsp;</p><p>&bull; attacks of porphyria in patients with porphyria.</p><p>&nbsp;</p><p><strong>To report any side effects in KSA: </strong></p><p><strong>National Pharmacovigilance &amp;amp; amp; Drug Safety Centre (NPC)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Fax: +966-11-205-7662</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Toll free phone: 8002490000</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>E-mail: </strong><strong>npc.drug@sfda.gov.sa</strong><strong> </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Website: </strong><strong>www.sfda.gov.sa/npc</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>According to toxicity studies in animals or clinical pharmacology studies performed with supra-therapeutic doses, the most important signs to be expected following acute overdose of levofloxacin tablets are central nervous system symptoms such as confusion, dizziness, impairment of consciousness, and convulsive seizures, increases in QT interval as well as gastro-intestinal reactions such as nausea and mucosal erosions.</p><p>&nbsp;</p><p>CNS effects including confusional state, convulsion, hallucination, and tremor have been observed in post marketing experience.</p><p>&nbsp;</p><p>In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Antacids may be used for protection of gastric mucosa. Haemodialysis, including peritoneal dialysis and CAPD, are not effective in removing levofloxacin from the body. No specific antidote exists.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: quinolone antibacterials, fluoroquinolones</p><p>ATC code: J01MA12</p><p>Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class and is the S (-) enantiomer of the racemic active substance ofloxacin.</p><p><em>Mechanism of action</em></p><p>As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA-DNA-gyrase complex and topoisomerase IV.</p><p><em>&nbsp;</em></p><p><em>PK/PD relationship </em></p><p>The degree of the bactericidal activity of levofloxacin depends on the ratio of the maximum concentration in serum (Cmax) or the area under the curve (AUC) and the minimal inhibitory concentration (MIC).</p><p><em>Mechanism of resistance</em></p><p>Resistance to levofloxacin is acquired through a stepwise process by target site mutations in both type II topoisomerases, DNA gyrase and topoisomerase IV. Other resistance mechanisms such as permeation barriers (common in <em>Pseudomonas aeruginosa) </em>and efflux mechanisms may also affect susceptibility to levofloxacin.</p><p>Cross-resistance between levofloxacin and other fluoroquinolones is observed. Due to the mechanism of action, there is generally no cross-resistance between levofloxacin and other classes of antibacterial agents.</p><p><em>Breakpoints</em></p><p>The EUCAST recommended MIC breakpoints for levofloxacin, separating susceptible from intermediately susceptible organisms and intermediately susceptible from resistant organisms are presented in the below table for MIC testing (mg/l).</p><p>EUCAST clinical MIC breakpoints for levofloxacin (version 2.0, 2012-01-01):</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p><strong>Pathogen</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible </strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriacae</p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas spp. </em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Acinetobacter spp. </em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus spp. </em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>S. pneumoniae <sup>1</sup></em></p></td><td style="vertical-align:top"><p>&le;2 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A,B,C,G </em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>H. influenzae<sup>2, 3</sup></em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;1 mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>M. catarrhalis <sup>3</sup></em></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;1 mg/l</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<sup>4</sup></p></td><td style="vertical-align:top"><p>&le;1 mg/l</p></td><td style="vertical-align:top"><p>&gt;2 mg/l</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>1. The breakpoints for levofloxacin relate to high dose therapy.</p><p>2. Low-level fluoroquinolone resistance (ciprofloxacin MIC&#39;s of 0.12-0.5 mg/l) may occur but there is no evidence that this resistance is of clinical importance in respiratory tract infections with <em>H. influenzae.</em></p><p>3. Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory. Until there is evidence regarding clinical response for confirmed isolates with MIC above the current resistant breakpoint they should be reported resistant.</p><p>4. Breakpoints apply to an oral dose of 500 mg x 1 to 500 mg x 2 and an intravenous dose of 500 mg x 1 to 500 mg x 2</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Commonly susceptible species</u></strong></p><p><strong><em><u>Aerobic Gram-positive bacteria</u></em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacillus anthracis </em></p><p><em>Staphylococcus aureus methicillin-susceptible</em></p><p><em>Staphylococcus saprophyticus</em></p><p><em>Streptococci, group C and G</em></p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae </em></p><p><em>Streptococcus pyogenes </em></p></td></tr><tr><td style="vertical-align:top"><p><strong><em><u>Aerobic Gram- negative bacteria</u></em></strong></p><p><em>Eikenella corrodens</em></p><p><em>Haemophilus influenzae</em></p><p><em>Haemophilus para-influenzae</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Moraxella catarrhalis</em></p><p><em>Pasteurella multocida</em></p><p><em>Proteus vulgaris</em></p><p><em>Providencia rettgeri</em></p><p><strong><em><u>Anaerobic bacteria</u></em></strong></p><p><em>Peptostreptococcus</em></p><p><strong><em><u>Other</u></em></strong></p><p><em>Chlamydophila pneumoniae</em></p><p><em>Chlamydophila psittaci</em></p><p><em>Chlamydia trachomatis</em></p><p><em>Legionella pneumophila</em></p><p><em>Mycoplasma pneumoniae</em></p><p><em>Mycoplasma hominis</em></p><p><em>Ureaplasma urealyticum</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Species for which acquired resistance may be a problem</u></strong></p><p><strong><em><u>Aerobic Gram-positive bacteria</u></em></strong></p><p><em>Enterococcus faecalis</em></p><p><em>Staphylococcus aureus </em>methicillin-resistant<sup>#</sup></p><p>Coagulase negative <em>Staphylococcus spp</em></p><p><strong><em><u>Aerobic Gram- negative bacteria</u></em></strong></p><p><em>Acinetobacter baumannii</em></p><p><em>Citrobacter freundii</em></p><p><em>Enterobacter aerogenes</em></p><p><em>Enterobacter cloacae</em></p><p><em>Escherichia coli</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Morganella morganii</em></p><p><em>Proteus mirabilis</em></p><p><em>Providencia stuartii</em></p><p><em>Pseudomonas aeruginosa</em></p><p><em>Serratia marcescens</em></p><p><strong><em><u>Anaerobic bacteria</u></em></strong></p><p><em>Bacteroides fragilis</em></p><p><strong><u>Inherently Resistant Strains</u></strong></p><p><strong><em><u>Aerobic Gram-positive bacteria</u></em></strong></p><p><em>Enterococcus faecium</em></p></td></tr></tbody></table><p><sup># </sup>Methicillin-resistant <em>S. aureus </em>are very likely to possess co-resistance to fluoroquinolones, including levofloxacin.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Orally administered levofloxacin is rapidly and almost completely absorbed with peak plasma concentrations being obtained within 1 - 2 h. The absolute bioavailability is 99 - 100 %.</p><p>Food has little effect on the absorption of levofloxacin.</p><p>Steady state conditions are reached within 48 hours following a 500 mg once or twice daily dosage regimen.</p><p><u>Distribution</u></p><p>Approximately 30 - 40 % of levofloxacin is bound to serum protein.</p><p>The mean volume of distribution of levofloxacin is approximately 100 l after single and repeated 500 mg doses, indicating widespread distribution into body tissues.</p><p><u>Penetration into tissues and body fluids:</u></p><p>Levofloxacin has been shown to penetrate into bronchial mucosa, epithelial lining fluid, alveolar macrophages, lung tissue, skin (blister fluid), prostatic tissue and urine. However, levofloxacin has poor penetration into cerebro-spinal fluid.</p><p><u>Biotransformation</u></p><p>Levofloxacin is metabolised to a very small extent, the metabolites being desmethyl-levofloxacin and levofloxacin N-oxide. These metabolites account for &lt;5 % of the dose and are excreted in urine. Levofloxacin is stereochemically stable and does not undergo chiral inversion.</p><p><u>Elimination</u></p><p>Following oral and intravenous administration of levofloxacin, it is eliminated relatively slowly from the plasma (t<sub>&frac12;</sub> : 6 - 8 h). Excretion is primarily by the renal route (&gt;85 % of the administered dose).</p><p>The mean apparent total body clearance of levofloxacin following a 500 mg single dose was 175 +/-29.2 ml/min.</p><p>There are no major differences in the pharmacokinetics of levofloxacin following intravenous and oral administration, suggesting that the oral and intravenous routes are interchangeable.</p><p><u>Linearity </u></p><p>Levofloxacin obeys linear pharmacokinetics over a range of 50 to 1000 mg.</p><p><u>Special populations</u></p><p><em>Subjects with renal insufficiency</em></p><p>The pharmacokinetics of levofloxacin are affected by renal impairment. With decreasing renal function renal elimination and clearance are decreased, and elimination half-lives increased as shown in the table below:</p><p>Pharmacokinetics in renal insufficiency following single oral 500 mg dose</p><table border="1" cellspacing="0" cellpadding="0" style="width:553px"><tbody><tr><td style="vertical-align:top"><p>Cl<sub>cr</sub> [ml/min]</p></td><td style="vertical-align:top"><p>&lt; 20</p></td><td style="vertical-align:top"><p>20 - 49</p></td><td style="vertical-align:top"><p>50 - 80</p></td></tr><tr><td style="vertical-align:top"><p>Cl<sub>R</sub> [ml/min]</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>57</p></td></tr><tr><td style="vertical-align:top"><p>t<sub>1/2</sub> [h]</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>9</p></td></tr></tbody></table><p><em>Elderly subjects</em></p><p>There are no significant differences in levofloxacin pharmacokinetics between young and elderly subjects, except those associated with differences in creatinine clearance.</p><p><em>Gender differences</em></p><p>Separate analysis for male and female subjects showed small to marginal gender differences in levofloxacin pharmacokinetics. There is no evidence that these gender differences are of clinical relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential and toxicity to reproduction and development.</p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats and its only effect on fetuses was delayed maturation as a result of maternal toxicity.</p><p>Levofloxacin did not induce gene mutations in bacterial or mammalian cells but did induce chromosome aberrations in Chinese hamster lung cells in vitro. These effects can be attributed to inhibition of topoisomerase II. In vivo tests (micronucleus, sister chromatid exchange, unscheduled DNA synthesis, dominant lethal tests) did not show any genotoxic potential.</p><p>Studies in the mouse showed levofloxacin to have phototoxic activity only at very high doses. Levofloxacin did not show any genotoxic potential in a photomutagenicity assay, and it reduced tumour development in a photocarcinogenity study.</p><p>In common with other fluoroquinolones, levofloxacin showed effects on cartilage (blistering and cavities) in rats and dogs. These findings were more marked in young animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The other ingredients are: Crospovidone, microcrystalline cellulose, sodium stearyl fumarate, hypromellose, talc, yellow iron oxide (E172), red iron oxide (E172), Opadry-Y-1-7000 (hypromellose, titanium dioxide, macrogol).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months for Livador 750
36 months for Livador 250 mg and 500 mg 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Livador</strong><sup>&reg;</sup> is packed in aluminium blisters each containing 7 tablets, these blisters are enclosed in a carton along with an insert.</p><p><strong>Livador<sup>&reg;</sup> 250 Film Coated Tablets: </strong>Packs of 7 tablets (one blister) and 350 tablets (50 blisters).<strong> </strong>Each tablet contains 250 mg Levofloxacin (as levofloxacin hemihydrate).</p><p><strong>Livador<sup>&reg;</sup> 500 Film Coated Tablets: </strong>Packs of 7 tablets (one blister) and 350 tablets (50 bilsters).<strong> </strong>Each tablet contains 500 mg Levofloxacin (as levofloxacin hemihydrate).</p><p><strong>Livador<sup>&reg;</sup> 750 Film Coated Tablets: </strong>Packs of 5 tablets (one bilster).<strong> </strong>Each tablet contains 750 mg Levofloxacin (as levofloxacin hemihydrate).</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As for all medicines, any unused medicinal product should be disposed of accordingly and in compliance with local environmental regulations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development and Investment Co. Ltd
P.O.Box 9364 
Na’ur - Amman - Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                28/01/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>